Medicine and Dentistry
Natural Killer Cell
100%
Messenger RNA
46%
Cohort Analysis
46%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
CD20
46%
Cellular Immunity
46%
Infection
46%
Multiple Sclerosis
46%
Humoral Immunity
46%
Multiple Myeloma
46%
Therapeutic Use
46%
Ocrelizumab
23%
Receptor Binding
23%
T Cell
19%
Diseases
19%
Clinical Trial
19%
COVID-19 Vaccination
15%
Immunoglobulin G
15%
Cancer
13%
Effector Cell
12%
Hematologic Malignancy
12%
B Cell
12%
Immunotherapy
12%
Cell Therapy
12%
Immunosurveillance
11%
Cytotoxicity
11%
COVID-19
7%
Virus Nucleocapsid
7%
Drug Antibody
7%
Cytotoxic T-Cell
7%
Adverse Effect
6%
Solid Malignant Neoplasm
6%
Malignant Neoplasm
6%
Graft Versus Host Reaction
6%
Autoimmune Disease
6%
Toxicity and Intoxication
6%
Cytokine Release Syndrome
6%
Chimeric Antigen Receptor T-Cell Immunotherapy
6%
Chimeric Antigen Receptor T-Cell
6%
Biological Activity
5%
Peripheral Blood Mononuclear Cell
5%
Flow Cytometry
5%
Cell Differentiation
5%
Immunology and Microbiology
Natural Killer Cell
93%
Breakthrough Infection
46%
Adoptive Immunity
46%
Multiple Sclerosis
46%
Humoral Immunity
46%
CD20
46%
Severe Acute Respiratory Syndrome Coronavirus 2
46%
Chimeric Antigen Receptor Natural Killer Cell
46%
Multiple Myeloma
46%
Receptor Binding
23%
Ocrelizumab
23%
T Cell
19%
Immunoglobulin G
15%
Immunosurveillance
11%
Cytotoxicity
11%
Drug Antibody
7%
Virus Nucleocapsid
7%
CD4
7%
Cytotoxic T-Cell
7%
COVID-19
7%
Blood Level
7%
Spike
7%
Cell Engineering
6%
Immunotherapy
5%
B Cell
5%
Effector Cell
5%
Cell Differentiation
5%
Peripheral Blood Mononuclear Cell
5%
Preclinical Study
5%
Biological Activity
5%
Pharmacology, Toxicology and Pharmaceutical Science
Chimeric Antigen Receptor
46%
Multiple Myeloma
46%
Diseases
16%
Clinical Trial
16%
Immunotherapy
11%
Hematologic Malignancy
11%
Cytotoxicity
5%
Solid Malignant Neoplasm
5%
Graft Versus Host Reaction
5%
Cytokine Release Syndrome
5%
Autoimmune Disease
5%
Toxicity and Intoxication
5%
Malignant Neoplasm
5%
